Crowdonomics
Aphios Pharma

Reg CF · Common Stock · Oct 2024

ClosedReached targetReg CFCommon Equity
via Netcapital · last checked Sep 25, 2026
Raised
$65K / $618K max
11% of ceiling · target hit day 7
Investors
—
—
Estimated pre-money
$69M
—

Raised over time

Cumulative raised
$112K$56K$0
Oct 11, 2024 · openedSep 30, 2025 · last reading
Target ($10K) hit — Oct 18, 2024, day 7Deadline Oct 1, 2025 — 1 days out

Left axis: cumulative dollars raised. Live figures via Netcapital, last checked Sep 25, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$0
−$36K
FY2022
$0
−$822
FY2023
RevenueNet income
Metric
FY2022 unaudited
FY2023 unaudited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$36,427
-$822
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$38,761
$39,583
Long-term debt
$0
$0
Total liabilities
$38,761
$39,583
Other
Headcount
5
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

7 amendments
  1. Jul 10, 2025
    • Deadline Jul 12, 2025 → Oct 1, 2025

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗
  2. Jul 1, 2025
    • Deadline Jul 11, 2025 → Jul 12, 2025

    “updated cover image and video”

    Form C/A on EDGAR ↗
  3. Apr 15, 2025
    • Deadline Apr 30, 2025 → Jul 11, 2025

    “issuer extended the offering and updated the offering to include 2024 financial statements.”

    Form C/A on EDGAR ↗
  4. Apr 4, 2025
    No change to filed terms

    “short pitch and cover image updates”

    Form C/A on EDGAR ↗
  5. Mar 31, 2025
    • Deadline Apr 1, 2025 → Apr 30, 2025

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗
  6. Jan 31, 2025
    No change to filed terms

    “issuer updates every section of the offering page.”

    Form C/A on EDGAR ↗
  7. Jan 7, 2025
    • Deadline Jan 17, 2025 → Apr 1, 2025

    “issuer extended the offering deadline.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Est. pre-money$69M
Price / share$3.44
Shares offered2,907

Estimated, not stated: $3.44 × 20,046,502 securities outstanding as of Dec 31, 2023 (Form C-AR filed Apr 30, 2024, p. 22).

Offering details

Target$10,000
Max$617,999
Min investment$100
OpenedOct 11, 2024
DeadlineOct 1, 2025
ClosedOct 1, 2025
Days active355

Links & provenance

Source: SEC EDGAR
0001669191-24-000983
Last synced Sep 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.